You are here



The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

29 October 2014

Randomised PrEP trials close early due to highly effective results.

A randomised PrEP trial has closed early due to highly effective results. IPERGAY is the second European PrEP study to be closed early due to high effectiveness. It follows the closure of another randomised study, PROUD, that also was cut short due to highly significant results. This is promising news for changing the future of HIV prevention and treatment, especially for men who have sex with men (MSM).